Results 161 to 170 of about 86,629 (276)

Bortezomib-based treatment for multiple myeloma patients with renal impairment

, 2016
Wanqiu Zhu, Wen-Ming Chen
openalex   +1 more source

Priming Mesenchymal Stem/Stromal Cells with a Combination of a Low Dose of IFN-γ and Bortezomib Results in Potent Suppression of Pathogenic Th17 Immunity Through the IDO1-AHR Axis [PDF]

, 2022
Ha Young Park, Chae Eun Kim, Soung-Min Lee, Joo Mi Ahn, Eun Hye Yoon, Minjoo Yoo, Jung‐Mi Kim, Jiyeon Back, Dae Hwi Park, Won Hee Jang, Byungsuk Kwon, Su‐Kil Seo   +11 more
openalex   +1 more source

Bortezomib, Melphalan, and Prednisone (VMP) Regimen for Multiple Myeloma

, 2015
Samantha Bryant, Dominic A. Solimando, J. Aubrey Waddell   +2 more
openalex   +2 more sources

Supplementary Data from Bortezomib Primes Neuroblastoma Cells for TRAIL-Induced Apoptosis by Linking the Death Receptor to the Mitochondrial Pathway

, 2023
Ivonne Naumann, Roland Kappler, Dietrich von Schweinitz, Klaus‐Michael Debatin, Simone Fulda   +4 more
openalex   +1 more source

Pralatrexate Is Synergistic with the Proteasome Inhibitor Bortezomib in In vitro and In vivo Models of T-Cell Lymphoid Malignancies [PDF]

, 2010
Enrica Marchi, Luca Paoluzzi, Luigi Scotto, Venkatraman Seshan, Jasmine Zain, Pier Luigi Zinzani, Owen A. O’Connor   +6 more
openalex   +1 more source

A case of a digitate injection site reaction from subcutaneous bortezomib in a patient with myeloma. [PDF]

SAGE Open Med Case Rep
Creighton R, Eglington T, Chen LYC, Sutherland AE.   +3 more
europepmc   +1 more source

Data from PCI-24781 Induces Caspase and Reactive Oxygen Species–Dependent Apoptosis Through NF-κB Mechanisms and Is Synergistic with Bortezomib in Lymphoma Cells

, 2023
Savita Bhalla, Sriram Balasubramanian, Kevin A. David, Mint Sirisawad, Joseph J. Buggy, Lauren Mauro, Sheila Prachand, Richard Miller, Leo I. Gordon, Andrew M. Evens   +9 more
openalex   +1 more source

Pharmacovigilance study on neurological adverse reactions of proteasome inhibitors in the FDA adverse event reporting system. [PDF]

Front Pharmacol
Li S, Ling T, Liu Y, Li J.
europepmc   +1 more source

Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL [PDF]

, 2013
Kwan Yeung Wong, Thomas Sk Wan, Chi Chiu So, Chor Sang Chim   +3 more
openalex   +1 more source

The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry [PDF]

The Janssen-Cilag proposal for a risk-sharing agreement regarding bortezomib received a welcome signal from NICE. The Office of Fair Trading report included risk-sharing agreements as an available tool for the National Health Service. Nonetheless, recent
Barros, Pedro Pita
core   +1 more source